Skip to main content
Log in

Abuse-deterrent formulation of morphine saves healthcare costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 US dollars

Reference

  • Rossiter LF, et al. Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine. ClinicoEconomics and Outcomes Research 2020: 35-44, No. 12, 15 Jan 2020. Available from: URL: https://doi.org/10.2147/CEOR.S226607

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abuse-deterrent formulation of morphine saves healthcare costs. PharmacoEcon Outcomes News 846, 3 (2020). https://doi.org/10.1007/s40274-020-6542-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6542-x

Navigation